European Markets for Diabetes Monitoring, Treatment and Drug Delivery

  • February 2013
  • -
  • iData Research, Inc.
  • -
  • 250 pages

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.
This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring

Main Segments Included:
- Traditional blood glucose monitoring
- Blood glucose meters
- Blood glucose test strips
- Lancets and lancing devices
- Insulin
- Insulin syringes
- Insulin pens
- Insulin pumps
- Artificial pancreas


Companies Listed in Report:
- Sanofi
- Johnson & Johnson
- Eli Lilly
- Abbott
- Roche
- Bayer
- Medtronic
- Menarini
- Artsana
- Becton Dickinson
- Terumo
- Sooil
- B Braun
- Dexcom
- Novo Nordisk

Reasons To Buy:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.

Table Of Contents

EXECUTIVE SUMMARY1
1.1 EUROPEAN MARKETS FOR DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY.1
1.2 TRADITIONAL BLOOD GLUCOSE MONITORING MARKET2
1.3 CONTINUOUS GLUCOSE MONITORING MARKET .3
1.4 INSULIN MARKET4
1.5 INSULIN PEN MARKET ..4
1.6 INSULIN SYRINGE MARKET 5
1.7 INSULIN PUMP MARKET ..6
1.8 LEADING COMPETITORS ..7
RESEARCH METHODOLOGY8
2.1 RESEARCH SCOPE ..8
2.2 IDATA’S 9-STEP METHODOLOGY 8
Step 1: Project Initiation and Team Selection..9
Step 2: Prepare Data Systems and Perform Secondary Research ..11
Step 3: Preparation for Interviews and Questionnaire Design.12
Step 4: Performing Primary Research ..13
Step 5: Research Analysis: Establishing Baseline Estimates.15
Step 6: Market Forecast and Analysis16
Step 7: Identify Strategic Opportunities18
Step 8: Final Review and Market Release19
Step 9: Customer Feedback and Market Monitoring .19
EUROPEAN DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET.20
3.1 INTRODUCTION .20
3.1.1 Types of Diabetes .20
3.1.1.1 Type 1 Diabetes .20
3.1.1.2 Type 2 Diabetes .20
3.1.1.3 Gestational Diabetes ..21
3.1.1.4 Prediabetes.21
3.1.2 Diabetes Complications 22
3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes.24
3.1.4 Signs and Symptoms 25
3.1.5 Diabetes Monitoring..26
3.1.5.1 Initial Diagnosis..26
3.1.5.2 Blood Glucose Monitoring Systems.27
3.1.5.3 Urinary Glucose Monitoring..27
3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices..27
3.1.6 Treatment 29
3.1.6.1 Lifestyle Measures..29
3.1.6.2 Insulin29
3.1.6.3 Insulin Types .29
3.1.6.4 Oral Antidiabetic Drugs29
3.1.6.5 Injectable Antidiabetic Drugs 30
3.1.7 Drug Delivery Systems ..30
3.1.7.1 Insulin Syringes .30
3.1.7.2 Insulin Pens 30
3.1.7.3 Insulin Pumps30
3.1.7.4 Inhaled Insulin..30
3.2 CURRENCY EXCHANGE RATE.32
3.3MARKET OVERVIEW..33
3.4 TREND ANALYSIS BY SEGMENT 39
3.5MARKET DRIVERS AND LIMITERS 42
3.5.1 Market Drivers .42
3.5.2 Market Limiters 43
3.6 COMPETITIVE ANALYSIS ..45
3.6.1 Leading Competitors ..45
3.6.2 Market Concentration 51
3.7MERGERS AND ACQUISITIONS53
COUNTRY PROFILES54
4.1 INTRODUCTION .54
4.1.1 Population ..54
4.1.2 GDP per Capita54
4.1.3 Units ..54
4.1.4 Price Index .54
4.2 GERMANY55
4.3 FRANCE.56
4.4 UNITED KINGDOM ..57
4.5 ITALY.58
4.6 SPAIN .59
4.7 BENELUX .60
4.8 SCANDINAVIA61
4.9 AUSTRIA ..62
4.10 SWITZERLAND 63
4.11 PORTUGAL 64
TRADITIONAL BLOOD GLUCOSE MONITORING MARKET..65
5.1 INTRODUCTION .65
5.2MARKET OVERVIEW..67
5.3MARKET ANALYSIS AND FORECAST ..71
5.4MARKET DRIVERS AND LIMITERS 75
5.4.1 Market Drivers .75
5.4.2 Market Limiters 76
5.5 COMPETITIVE ANALYSIS ..77
BLOOD GLUCOSE METER MARKET ..82
6.1 INTRODUCTION .82
6.2MARKET ANALYSIS AND FORECAST ..83
6.3MARKET DRIVERS AND LIMITERS 90
6.3.1 Market Drivers .90
6.3.2 Market Limiters 90
6.4 COMPETITIVE ANALYSIS ..92
BLOOD GLUCOSE TEST STRIP MARKET97
7.1 INTRODUCTION .97
7.2MARKET ANALYSIS AND FORECAST ..98
7.3MARKET DRIVERS AND LIMITERS .105
7.3.1 Market Drivers ..105
7.3.2 Market Limiters .106
7.4 COMPETITIVE ANALYSIS 107
LANCET AND LANCING DEVICE MARKET 112
8.1 INTRODUCTION ..112
8.2MARKET ANALYSIS AND FORECAST 113
8.3MARKET DRIVERS AND LIMITERS .120
8.3.1 Market Drivers ..120
8.3.2 Market Limiters .120
8.4 COMPETITIVE ANALYSIS 122
CONTINUOUS GLUCOSE MONITORING MARKET..128
9.1 INTRODUCTION ..128
9.2MARKET OVERVIEW129
9.2.1 Total CGM Market 129
9.2.2 Emerging Markets: Non-Invasive CGM.129
9.3MARKET ANALYSIS AND FORECAST 133
9.3.1 Total CGM Market 133
9.3.2 CGM System Market 135
9.3.3 CGM Sensor Market.136
9.4MARKET DRIVERS AND LIMITERS .137
9.4.1 Market Drivers ..137
9.4.2 Market Limiters .138
9.5 COMPETITIVE ANALYSIS 140
INSULIN MARKET .143
10.1 INTRODUCTION 143
10.1.1 Insulin Types 143
10.2MARKET ANALYSIS AND FORECAST .146
10.3MARKET DRIVERS AND LIMITERS ..153
10.3.1 Market Drivers .153
10.3.2 Market Limiters 154
10.4 COMPETITIVE ANALYSIS .155
INSULIN PEN MARKET .157
11.1 INTRODUCTION 157
11.2MARKET ANALYSIS AND FORECAST .158
11.3MARKET DRIVERS AND LIMITERS ..165
11.3.1 Market Drivers .165
11.3.2 Market Limiters 165
11.4 COMPETITIVE ANALYSIS .166
INSULIN SYRINGE MARKET168
12.1 INTRODUCTION 168
12.2MARKET ANALYSIS AND FORECAST .169
12.3MARKET DRIVERS AND LIMITERS ..176
12.3.1 Market Drivers .176
12.3.2 Market Limiters 176
12.4 COMPETITIVE ANALYSIS .178
INSULIN PUMP MARKET.182
13.1 INTRODUCTION 182
13.2MARKET OVERVIEW.184
13.3MARKET ANALYSIS AND FORECAST .188
13.3.1 Total Traditional Insulin Pump Market ..188
13.3.1.1 Traditional Insulin Pump Market193
13.3.1.2 Infusion Set Market 199
13.3.2 Emerging Markets: Patch Pump Market205
13.3.2.1 Patch Pump PDM Market ..207
13.3.2.2 Insulin Pod Market.208
13.3.3 Emerging Markets: Simple Pump Market ..209
13.4MARKET DRIVERS AND LIMITERS ..211
13.4.1 Market Drivers .211
13.4.2 Market Limiters 212
13.5 COMPETITIVE ANALYSIS .214
13.5.1 Traditional Pump Market Competitors 214
13.5.2 Patch Pump Market Competitors 218
13.5.3 Emerging Competitors .219
APPENDIX 1: ARTIFICIAL PANCREAS 220
14.1MECHANICAL ARTIFICIAL PANCREAS..220
14.2 BIO-ARTIFICIAL PANCREAS221
ABBREVIATIONS ..222

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Automated Microbiology: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country strategic analysis of the major business opportunities ...

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

Emerging Opportunities in the Global Virology and Bacteriology Testing Market

  • $ 21 100
  • Industry report
  • June 2014
  • by Venture Planning Group

“Emerging Opportunities in the Global Virology and Bacteriology Testing Market” is a new seven-country strategic analysis of major business opportunities emerging in the infectious disease testing ...

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape

  • $ 21 100
  • Industry report
  • May 2014
  • by Venture Planning Group

“New Frontiers in Coagulation Testing: Global Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group's new seven-country report designed to help current suppliers and potential ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.